Efficacy of medical therapy and antireflux surgery to prevent Barrett's metaplasia in patients with gastroesophageal reflux disease
- PMID: 11685025
- PMCID: PMC1422086
- DOI: 10.1097/00000658-200111000-00007
Efficacy of medical therapy and antireflux surgery to prevent Barrett's metaplasia in patients with gastroesophageal reflux disease
Abstract
Objective: To investigate whether Barrett's metaplasia may develop despite effective medical therapy.
Summary background data: Gastroesophageal reflux disease has a multifactorial etiology. Therefore, medical treatment may not prevent complications of reflux disease.
Methods: Eighty-three patients with reflux disease and mild esophagitis were prospectively studied for the development of Barrett's metaplasia while receiving long-term therapy with proton pump inhibitors and cisapride. Only patients who had effective control of reflux symptoms and esophagitis were included. The surveillance time was 2 years. The outcome of these 83 patients was compared with that of 42 patients in whom antireflux surgery was performed with a median follow-up of 3.5 years.
Results: Twelve (14.5%) patients developed Barrett's while receiving medical therapy; this was not seen after surgery. Patients developing Barrett's had a weaker lower esophageal sphincter and peristalsis before treatment than patients with uncomplicated disease.
Conclusions: Antireflux surgery is superior to medical therapy in the prevention of Barrett's metaplasia. Therefore, patients with reflux disease who have a weak lower esophageal sphincter and poor esophageal peristalsis should undergo antireflux surgery, even if they have only mild esophagitis.
Figures
Comment in
-
Barrett's esophagus: are there any easy answers?Curr Surg. 2003 Jul-Aug;60(4):364-6. doi: 10.1016/s0149-7944(03)00109-0. Curr Surg. 2003. PMID: 15212031 No abstract available.
References
-
- Wetscher GJ, Redmond EJ, Vitito L. Pathophysiology of gastroesophageal reflux disease. In: Hinder RA, ed. Gastroesophageal reflux disease. Austin, Texas: Medical Intellegence Unit, R.G. Landes Co.; 1993: 7–29.
-
- Wetscher GJ, Hinder RA, Perdikis G, et al. Three-dimensional imaging of the lower esophageal sphincter in healthy subjects and gastroesophageal reflux. Dig Dis Sci 1996; 41: 2377–2382. - PubMed
-
- Eckhardt VF. Does healing of esophagitis improve esophageal motor function? Dig Dis Sci 1988; 33: 161–165. - PubMed
-
- Stein HJ, Bremner RM, Jamieson J, et al. Effect of Nissen fundoplication on esophageal motor function. Arch Surg 1992; 127: 788–791. - PubMed
-
- Perdikis G, Wilson P, Redmond EJ, et al. Enteric hormone abnormalities are associated with gastroesophageal reflux disease. Am J Surg 1994; 176: 186–192. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
